Overexpression of the human major vault protein in astrocytic brain tumor cells

International Journal of Cancer

Volumn 94, Issue 3, 2001, Pages 377-382

  Berger, Walter ^a   Spiegl Kreinecker, Sabine ^a   Buchroithner, Johanna ^b   Elbling, Leonilla ^a   Pirker, Christine ^a   Fischer, Johannes ^b   Micksche, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Astrocytes; Brain tumor; Glioma; Human major vault protein; Lung resistance protein; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; LUNG RESISTANCE PROTEIN; MAJOR HUMAN VAULT PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; MENINGIOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ASTROCYTES; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE; CELLS, CULTURED; CYTOPLASM; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOBLOTTING; MENINGIOMA; MICROSCOPY, FLUORESCENCE; PHENOTYPE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0035501672     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1486     Document Type: Article

References (24)

1. Principles of treatment of malignant gliomas in adults: An overview
2. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
3. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells
4. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
5. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and Adriamycin in human glioma cells
6. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors
7. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: Activation by short-term exposure to antineoplastic drugs
8. Vaults are the answer, what is the question?
9. Vaults: Large cytoplasmic RNP's that associate with cytoskeletal elements
10. Vaults are upregulated in multidrug-resistant cancer cell lines
11. Chemosensitivity of glioma cells in vitro: A meta analysis
12. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines
13. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
14. Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma
15. Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma
16. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
17. The drug resistance-related protein LRP is the human major vault protein
18. The M-r 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines
19. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex
20. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells
21. Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors
22. Vault immunofluorescence in the brain: New insights regarding the origin of microglia
23. Expression of carcinoembryonic or related cross-reacting antigens in primary pediatric neuroectodermal brain tumors
24. Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections